NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-086-1999-0-EP-03 Nucleic Acid and Amino Acid Sequences of Hemoglobin-Response Genes in...... EP National Stage 00905649.0 Abandoned
NCI E-086-1999-0-AU-04 Glycoclipid Enzyme-Polymer Conjugates AU National Stage 27299/00 Abandoned
NCI E-086-1999-0-PCT-02 NUCLEIC ACID AND AMINO ACID SEQUENCES OF HEMOGLOBIN-RESPONSE GENES IN CANDIDA ALBICANS AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN THE DIAGNOSIS OF DISSEMINATED CANDIDA ALBICANS INFECTION PCT PCT PCT/US2000/001184 Expired
NCI E-086-1999-0-CA-05 Nucleic Acid and Amino Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of Reagents Derived From These Sequences in the Diagnosis of Disseminated Candida Albicans Infection CA National Stage 2363707 Abandoned
NCI E-142-1990-2-US-03 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY US CON 09/483,831 6417338 Expired PDF
NIDDK E-174-1998-0-US-02 Methods for Delivering Biologically Active Molecules Into Cells US ORD 09/483,434 6974698 Abandoned PDF
NIAID E-066-2000-0-PCT-01 Use of CCR5 Binding Chemokines To Stimulate Interleukin-12 (IL-12) Production By Lymphoid Dentritic Cells And The Use Of CCR5 Antagonists PCT PCT PCT/US00/01019 Abandoned
NIDDK E-176-1999-0-US-01 Methanocarba Cycloalkyl Nucleoside Analogues US 60/176,373 Abandoned
NCI E-028-1990-3-US-06 VECTOR WITH MULTIPLE TARGET RESPONSE ELEMENTS AFFECTING GENE EXPRESSION US CON 09/481,209 Abandoned
NCI E-022-1997-0-US-08 PROTEASE-ACTIVATABLE PSEUDOMONAS EXOTOXIN A-LIKE PROPROTEINS US DIV 09/479,479 6423513 Abandoned PDF
NCI E-260-1994-1-US-02 ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS EXPRESSING AND IMMUNOSTIMULATORY MOLECULE US CON 09/480,340 6548068 Expired PDF
NIAID E-070-1999-2-PCT-01 Novel HIV Related Peptides PCT PCT COMB PCT/US00/00372 Expired
NIAID E-070-1999-2-EP-02 Novel HIV Related Peptides EP National Stage 00904245.8 Abandoned
NIMH E-080-1999-0-EP-04 PREVENTION OF CHRONIC GRAFT REJECTION BY A COMBINATION OF IMMUNOTOXINS AND COSTIMULATION BLOCKERS EP National Stage 00904230.0 Abandoned
NIMH E-080-1999-0-CY-14 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 CY EP 00904230.0 Abandoned
NIMH E-080-1999-0-DK-15 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 DK EP 00904230.0 Abandoned
NIMH E-080-1999-0-CH-13 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 CH EP 00904230.0 Abandoned
NIMH E-080-1999-0-GB-19 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 GB EP 00904230.0 Abandoned
NIMH E-080-1999-0-SE-10 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 SE EP 00904230.0 Abandoned
NIMH E-080-1999-0-LI-23 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 LI EP 00904230.0 Abandoned
NIMH E-080-1999-0-LU-08 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 LU EP 00904230.0 Abandoned
NIMH E-080-1999-0-IE-21 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 IE EP 00904230.0 Abandoned
NIMH E-080-1999-0-IT-22 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 IT EP 00904230.0 Abandoned
NIMH E-080-1999-0-GR-20 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 GR EP 00904230.0 Abandoned
NIMH E-080-1999-0-AT-11 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 AT EP 00904230.0 Abandoned
NIMH E-080-1999-0-BE-12 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 BE EP 00904230.0 Abandoned
NIMH E-080-1999-0-FR-18 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 FR EP 00904230.0 Abandoned
NIMH E-080-1999-0-DE-07 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 DE EP 00904230.0 Abandoned
NIMH E-080-1999-0-FI-17 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 FI EP 00904230.0 Abandoned
NIMH E-080-1999-0-NL-25 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 NL EP 00904230.0 Abandoned
NIMH E-080-1999-0-MC-24 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 MC EP 00904230.0 Abandoned
NIMH E-080-1999-0-ES-16 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 ES EP 00904230.0 Abandoned
NIMH E-080-1999-0-PT-09 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 PT EP 00904230.0 Abandoned
NCI E-210-1998-0-CH-06 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods CH EP 00903134.5 Abandoned
NCI E-210-1998-0-GB-07 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods GB EP 00903134.5 Abandoned
NCI E-210-1998-0-IE-08 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods IE EP 00903134.5 Abandoned
NCI E-210-1998-0-EP-03 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods EP National Stage 00903134.5 Abandoned
NCI E-029-1990-0-HK-11 In Vitro Method of Determining the Presence of a Protein in an Isolated Biological Sample HK National Stage 00100071.2 Abandoned
NIMH E-080-1999-0-AU-03 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 AU National Stage 26017/00 Abandoned
NCI E-231-1998-0-PCT-02 Lentivirus Vector System PCT PCT PCT/US00/00390 Abandoned
NCI E-210-1998-0-PCT-02 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods PCT PCT PCT/US00/00265 Expired
NIMH E-080-1999-0-PCT-02 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 PCT PCT PCT/US00/00284 Expired
NCI E-021-1999-0-PCT-02 The CD4-CCR5 Interaction as a Target for Inhibitors of HIV Infection PCT PCT PCT/US00/00417 Abandoned
NIMH E-080-1999-0-CA-06 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 CA National Stage 2358435 Abandoned
NHGRI E-101-1997-0-US-02 PROBE-BASED ANALYSIS OF HETEROZYGOUS MUTATIONS USING TWO-COLOR LABELLING US CON 09/477,871 6342355 Expired PDF
NCI E-068-2000-0-US-01 Molecules That Influence Pathogen Resistance US 60/174,470 Abandoned
NINDS E-171-1999-0-US-01 High-Speed Interlaced Spin Echo Magnetic Resonance Imaging US 60/173,563 Abandoned
NICHD E-013-2000-0-US-01 Improved Process Development of 17alpha-acetoxy-11beta-(4-(N,N- dimethylamino)phenly)-21-Methoxy-19-norpregna-4,9-diene-3,20-dione US 60/173,470 Abandoned
NCI E-052-1995-1-JP-07 METHOD FOR INDUCING MONOCYTES TO EXHIBIT THE PHENOTYPE OF ACTIVATED MYELOID DENDRITIC CELLS JP National Stage 1999-505868 Abandoned
NCI E-148-1998-0-US-01 Molecular Clones With Mutated HIV GAG/POL and SIV GAG Genes US 60/173,036 Abandoned